[HTML][HTML] Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - Journal of …, 2021 - Springer
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - Journal of …, 2021 - go.gale.com
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.
Y Hu, R Tao, L Chen, Y Xiong, H Xue… - Journal of …, 2021 - search.ebscohost.com
Background: Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - Journal of …, 2021 - europepmc.org
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong, H Xue… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, C Lang, Y Xiong, H Xue… - Journal of …, 2021 - search.proquest.com
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
[PDF][PDF] Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu, C Yan… - 2021 - scholar.archive.org
Background: Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
[HTML][HTML] Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong… - Journal of …, 2021 - jnanobiotechnology.biomedcentral …
Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells
(MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for …
(MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for …
[HTML][HTML] Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
[PDF][PDF] Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Y Hu, R Tao, L Chen, Y Xiong, H Xue, L Hu… - 2021 - jnanobiotechnology.biomedcentral …
Background: Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …
stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising …